Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Sensitive Dehydrated Skins Cream

APR Applied Pharma Research S.A.
Hypoallergenic moisturizing cream for dermatitis and dehydrated skin espcially formulated for sensitive skin, thanks to the total absence of preservayives and perfumes

Mechanism of action

Excellent skin moisturising and protective properties

Full description

ATOSKIN cream is a dermocosmetic treatment for atopic, dehydrated and particularly delicate skin.

Preservatives and perfumes normally present in local-use preparations may cause specific skin sensitisation conditions; APR has developed a new formulation completely safe and hypoallergenic: ATOSKIN cream.

ATOSKIN cream is free from preservatives and perfumes, but its special combination of substances of a different nature and functional capacity ensures that the product is protected against yeasts, moulds and bacteria. Moreover the specific vehicle selection gives the product a pleasant smell without any perfumed additives . The microbiological and clinical results obtained show that ATOSKIN cream is self-preservative, non-irritant and hypoallergenic, has excellent skin moisturising and protective properties thanks to the synergistic action of sodium hyaluronate with aloe barbadensis and jojoba oil, which are able to ensure perfect long-term maintenance of the epidermal layer.

Microbiological and clinical tests performed on ATOSKIN cream

CHALLENGE TEST: evaluation of ATOSKIN cream self-preservative properties. Test results demonstrate that ATOSKIN cream is self-preservative.

Shelanski and Shelanski modified tests (repeated epicutaneous tests): evaluation of ATOSKIN cream hypoallergenic properties on 25 patients. The test results demonstrate that ATOSKIN cream is non irritant and hypoallergenic.

CLINICAL TEST for cosmetic evaluation of moisturising (corneometer) and protective (tewameter) properties on 20 patients. These clinical tests show that: - ATOSKIN cream provides excellent moisturisation in short term treatment (30 minutes) - ATOSKIN cream provides excellent moisturisation in long term treatment (45 days) - ATOSKIN cream provides an excellent barrier effect, in fact, after 60 days treatment, the TEWL (trans-epidermic water loss) decreases

Patent information

A complete standard EU registration file for the cosmetic product is available

Type of business relationship sought

Licensing/distribution agreement in available countries

Licensing contact

Mr Paolo Galfetti
CEO
Request more information

Company details

APR Applied Pharma Research S.A.
APR is a Swiss based R&D company offering innovative patent protected products for out-licensing as well as integrated and centrally managed R&D services on a contract basis.

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Bio-Europe 2008
Yissum Technology Transfer Hebrew University
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us